Characterization of a novel human anti-GD2 anti-idiotypic antibody GK8 DNA vaccine for immunotherapy in neuroblastoma

被引：0
|
作者：
Weixler, S. [1 ]
Fest, S. [1 ]
Huebener, N. [1 ]
Kruger, J. [1 ]
Gaedicke, G. [1 ]
Lode, H. [1 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
来源：
ACTA PAEDIATRICA | 2008年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [1] Characterization of a Novel Human Anti-GD2 Anti-Idiotypic Antibody GK8 DNA Vaccine for Immunotherapy in Neuroblastoma
    Weixler, S.
    Fest, S.
    Zeng, Y.
    Huebener, N.
    Gaedicke, G.
    Krueger, J.
    Lode, H. N.
    EUROPEAN JOURNAL OF PEDIATRICS, 2009, 168 (03) : 377 - 377
  • [2] Characterization and in vivo efficacy of a novel human anti-GD2 anti-idiotypic antibody GK8 DNA vaccine against neuroblastoma
    Weixler, S
    Fest, S
    Zeng, Y
    Huebener, N
    Bleeke, M
    Gaedicke, G
    Krüger, J
    Lode, HN
    KLINISCHE PADIATRIE, 2006, 218 (03): : 198 - 198
  • [3] Characterization and partial sequencing of a human anti-idiotypic antibody against anti-GD2 chimeric antibody CH14.18 from a patient treated for neuroblastoma
    Uttenreuther-Fischer, MM
    Neveling, N
    Yu, A
    Gaedicke, G
    Fischer, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S56 - S56
  • [4] Anti-GD2 immunotherapy for neuroblastoma
    Sait, Sameer
    Modak, Shakeel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (10) : 889 - 904
  • [5] Anti-GD2 antibody internalization by neuroblastoma as a mechanism of immunotherapy resistance
    Tibbetts, Rachelle J.
    Yeo, Kee Kiat
    Muthugounder, Sakunthala
    Asgharzadeh, Shahab
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Systemic interleukin-2 modulates the anti-idiotypic response to chimeric anti-GD2 antibody in patients with melanoma
    Albertini, MR
    Gan, J
    Jaeger, P
    Hank, JA
    Storer, B
    Schell, K
    Rivest, T
    Surfus, J
    Reisfeld, RA
    Schiller, JH
    Sondel, PM
    JOURNAL OF IMMUNOTHERAPY, 1996, 19 (04): : 278 - 295
  • [7] Immunotherapy with anti-GD2 monoclonal antibody in infants with high-risk neuroblastoma
    Kushner, Brian H.
    Modak, Shakeel
    Kramer, Kim
    Basu, Ellen M.
    Iglesias-Cardenas, Fiorella
    Roberts, Stephen S.
    Cheung, Nai-Kong, V
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (02) : 259 - 266
  • [8] Prolonged ILEUS Secondary to Anti-Gd2 Immunotherapy for Neuroblastoma
    Osuna Marco, M.
    Alcaide Alvarez, C.
    Barrio Merino, A.
    Cilla, C.
    Bengoechea, C.
    Lancharro, A.
    Villa Alcazar, M.
    Lopez-Ibor, B.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S524 - S524
  • [9] Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse
    Raffaghello, L
    Marimpietri, D
    Pagnan, G
    Pastorino, F
    Cosimo, E
    Brignole, C
    Ponzoni, M
    Montaldo, PG
    CANCER LETTERS, 2003, 197 (1-2) : 205 - 209
  • [10] Promising results of a pilot trial of a GD2 directed anti-idiotypic antibody as a vaccine for high risk neuroblastoma.
    Batova, A
    Yu, AL
    Strother, D
    Angelini, P
    Eskenazi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 801S - 801S
12345